SB-242,084
|
| (IUPAC) ime
|
| 6-hloro-5-metil-N-{6-[(2-metilpiridin-3-il)oksi]piridin-3-il]indolin-1-karboksamid
|
| Klinički podaci
|
| Identifikatori
|
| CAS broj
|
181632-25-7
|
| ATC kod
|
nije dodeljen
|
| PubChem[1][2]
|
3644637
|
| ChEMBL[3]
|
CHEMBL14563
|
| Hemijski podaci
|
| Formula
|
C21H19ClN4O2
|
| Mol. masa
|
394,853 g/mol
|
| SMILES
|
eMolekuli & PubHem
|
| InChI |
|---|
InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27)  Y
Key: GIUZEIJUFOPTMR-UHFFFAOYSA-N Y |
|
| Farmakoinformacioni podaci
|
| Trudnoća
|
?
|
| Pravni status
|
|
SB-242,084 je psihoaktivni lek i istraživačka hemikalija koja deluje kao selektivni antagonist za 5HT2C receptor.[4] On ima anksiolitičko dejstvo,[5] i pojačava dopaminsku signalizaciju u limbičnom sistemu.[6] On takođe ima kompleksno dejstvo na otpuštanje dopamina proizvedeno kokainom, povećavajući ga u pojedinim delovima mozga[7][8] i snižavajući ga u drugim.[9][10] Pokazano je da povišava efektivnost selektivnih inhibitora preuzimanja serotonina (SSRI), i da redukuje njihove nuspojave.[11][12] U životinjskim studijama, SB-242,084 proizvodi stimulansnu aktivnost, koja je donekle slična ali znatno slabija od kokaina i amfetamina.[13]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
- ↑ Kennett, GA; Wood, MD; Bright, F; Trail, B; Riley, G; Holland, V; Avenell, KY; Stean, T i dr.. (1997). „SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist”. Neuropharmacology 36 (4–5): 609–20. DOI:10.1016/S0028-3908(97)00038-5. PMID 9225286.
- ↑ Martin, JR; Ballard, TM; Higgins, GA (2002). „Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety”. Pharmacology, Biochemistry, and Behavior 71 (4): 615–25. DOI:10.1016/S0091-3057(01)00713-4. PMID 11888553.
- ↑ Di Matteo, V; Di Giovanni, G; Di Mascio, M; Esposito, E (1999). „SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system”. Neuropharmacology 38 (8): 1195–205. DOI:10.1016/S0028-3908(99)00047-7. PMID 10462132.
- ↑ Navailles, S; De Deurwaerdère, P; Porras, G; Spampinato, U (2004). „In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum”. Neuropsychopharmacology 29 (2): 319–26. DOI:10.1038/sj.npp.1300329. PMID 14560323.
- ↑ Navailles, S; Moison, D; Ryczko, D; Spampinato, U (2006). „Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors”. Journal of Neurochemistry 99 (4): 1311–9. DOI:10.1111/j.1471-4159.2006.04188.x. PMID 17018023.
- ↑ Navailles, S; Moison, D; Cunningham, KA; Spampinato, U (2008). „Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine”. Neuropsychopharmacology 33 (2): 237–46. DOI:10.1038/sj.npp.1301414. PMID 17429406.
- ↑ Leggio, GM; Cathala, A; Moison, D; Cunningham, KA; Piazza, PV; Spampinato, U (2009). „Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens”. Neuropharmacology 56 (2): 507–13. DOI:10.1016/j.neuropharm.2008.10.005. PMC 3130963. PMID 18977370.
- ↑ Cremers, TI; Giorgetti, M; Bosker, FJ; Hogg, S; Arnt, J; Mørk, A; Honig, G; Bøgesø, KP i dr.. (2004). „Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade”. Neuropsychopharmacology 29 (10): 1782–9. DOI:10.1038/sj.npp.1300474. PMID 15138437.
- ↑ Burghardt, NS; Bush, DE; McEwen, BS; Ledoux, JE (2007). „Acute SSRIs Increase Conditioned Fear Expression: Blockade with a 5-HT2C Receptor Antagonist”. Biological Psychiatry 62 (10): 1111–8. DOI:10.1016/j.biopsych.2006.11.023. PMC 2129095. PMID 17524369.
- ↑ Manvich, D. F.; Kimmel, H. L.; Cooper, D. A.; Howell, L. L. (2012). „The Serotonin 2C Receptor Antagonist SB 242084 Exhibits Abuse-Related Effects Typical of Stimulants in Squirrel Monkeys”. Journal of Pharmacology and Experimental Therapeutics. DOI:10.1124/jpet.112.195156. PMID 22685342.
|
|---|
|
|---|
| Agonisti: Azapironi: Alnespiron • Binospiron • Buspiron • Enilospiron • Eptapiron • Gepiron • Ipsapiron • Perospiron • Revospiron • Tandospiron • Tiospiron • Umespiron • Zalospiron; Antidepresivi: Etoperidon • Nefazodon • Trazodon; Antipsihotici: Aripiprazol • Asenapin • Klozapin • Kvetiapin • Ziprasidon; Ergolini: Dihidroergotamin • Ergotamin • Lisurid • Metisergid • LSD; Triptamini: 5-CT • 5-MeO-DMT • 5-MT • Bufotenin • DMT • Indorenat • Psilocin • Psilocibin; Drugi: 8-OH-DPAT • Adatanserin • Bay R 1531 • Befiradol • BMY-14802 • Kanabidiol • Dimemebfe • Ebalzotan • Eltoprazin • F-11,461 • F-12,826 • F-13,714 • F-14,679 • F-15,063 • F-15,599 • Flesinoksan • Flibanserin • Lesopitron • Lu AA21004 • LY-293,284 • LY-301,317 • MKC-242 • NBUMP • Osemozotan • Oksaflozan • Pardoprunoks • Piklozotan • Rauvolscin • Repinotan • Roksindol • RU-24,969 • S 14,506 • S-14,671 • S-15,535 • Sarizotan • SSR-181,507 • Sunepitron • U-92,016-A • Urapidil • Vilazodon • Ksaliproden • JohimbinAntagonisti: Antipsihotici: Iloperidon • Risperidon • Sertindol; Beta blokatori: Alprenolol • Cianopindolol • Jodocianopindolol • Oksprenolol • Pindobind • Pindolol • Propranolol • Tertatolol; Drugi: AV965 • BMY-7,378 • CSP-2503 • Dotarizin • Flopropion • GR-46611 • Isamoltan • Lekozotan • Metitepin/Metiotepin • MPPF • NAN-190 • PRX-00023 • Robalzotan • S-15535 • SB-649,915 • SDZ 216-525 • Spiperon • Spiramid • Spiroksatrin • UH-301 • WAY-100,135 • WAY-100,635 • Ksilamidin |
|---|
| |
|---|
| Agonisti: Lisergamidi: Dihidroergotamin • Metisergid; Triptani: Almotriptan • Avitriptan • Eletriptan • Frovatriptan • Naratriptan • Rizatriptan • Sumatriptan • Zolmitriptan; Triptamini: 5-CT • 5-Etil-DMT • 5-MT • 5-(Noniloksi)triptamin; Drugi: CP-135,807 • CP-286,601 • GR-46611 • L-694,247 • L-772,405 • PNU-109,291 • PNU-142,633Antagonisti: Lisergamidi: Metergolin; Drugi: Alniditan • BRL-15,572 • Elzasonan • GR-127,935 • Ketanserin • LY-310,762 • LY-367,642 • LY-456,219 • LY-456,220 • Metitepin/Metiotepin • Ritanserin • Johimbin • Ziprasidon |
|---|
| |
|---|
| |
|---|
|
|
|
|---|
| |
|---|
| |
|---|
| Agonisti: Fenetilamini: 2C-B • 2C-E • 2C-I • 2C-T-2 • 2C-T-7 • 2C-T-21 • DOB • DOC • DOI • DOM • MDA • MDMA • Meskalin; Piperazini: Aripiprazol • mCPP • TFMPP; Triptamini: 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Metil-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocibin; Drugi: A-372,159 • AL-38022A • CP-809,101 • Dimemebfe • Lorkaserin• Medifoksamin • MK-212 • Org 12,962 • ORG-37,684 • Oksaflozan • PNU-22394 • Ro60-0175 • Ro60-0213 • Vabicaserin • WAY-629 • WAY-161,503 • YM-348Antagonisti: Atipični antipsihotici: Klozapin • Iloperidon • Melperon • Olanzapin • Paliperidon • Pimozid • Hetiapin • Risperidon • Sertindol • Ziprasidon • Zotepin; Tipični antipsihotici: Hlorpromazin • Loksapin • Pipamperon; Antidepresivi: Agomelatin • Amitriptilin • Amoksapin • Aptazapin • Etoperidon • Fluoksetin • Mianserin • Mirtazapin • Nefazodon • Nortriptilin • Trazodon; Drugi: Adatanserin • Cinanserin • Ciproheptadin • Deramciklan • Dotarizin • Eltoprazin • Esmirtazapin • FR-260,010 • Ketanserin • Ketotifen • Latrepirdin • Lu AA24530 • Metitepin/Metiotepin • Metisergid • Pizotifen • Ritanserin • RS-102,221 • S-14,671 • SB-200,646 • SB-206,553 • SB-221,284 • SB-228,357 • SB-242,084 • SB-243,213 • SDZ SER-082 • Ksilamidin |
|---|
|
|
|
|---|
| |
|---|
| |
|---|
| |
|---|
| Agonisti: Lisergamidi: Dihidroergotamin • Ergotamin • Lisurid • LSD • Mesulergin • Metergolin • Metisergid; Triptamini: 2-Metil-5-HT • 5-BT • 5-CT • 5-MT • Bufotenin • E-6801 • E-6837 • EMD-386,088 • EMDT • LY-586,713 • N-Metil-5-HT • Triptamin; Drugi: WAY-181,187 • WAY-208,466Antagonisti: Antidepresanti: Amitriptilin • Amoksapin • Klomipramin • Doksepin • Mianserin • Nortriptilin; Atipični antipsihotici: Aripiprazol • Asenapin • Klozapin • Fluperlapin • Iloperidon • Olanzapin • Tiospiron; Tipični antipsihotici: Hlorpromazin • Loksapin; Drugi: BGC20-760 • BVT-5182 • BVT-74316 • EGIS-12,233 • GW-742,457 • Ketanserin • Latrepirdin • Lu AE58054 • Metitepin/Metiotepin • MS-245 • PRX-07034 • Ritanserin • Ro04-6790 • Ro 63-0563 • SB-258,585 • SB-271,046 • SB-357,134 • SB-399,885 • SB-742,457 |
|---|
| Agonisti: Lisergamidi: LSD; Triptamini: 5-CT • 5-MT • Bufotenin; Drugi: 8-OH-DPAT • AS-19 • Bifeprunoks • LP-12 • LP-44 • RU-24,969 • SarizotanAntagonisti: Lisergamidi: 2-Bromo-LSD • Bromokriptin • Dihidroergotamin • Ergotamin • Mesulergin • Metergolin • Metisergid; Antidepresanti: Amitriptilin • Amoksapin • Klomipramin • Imipramin • Maprotilin • Mianserin; Atipični antipsihotici: Amisulprid • Aripiprazol • Klozapin • Olanzapin • Risperidon • Sertindol • Tiospiron • Ziprasidon • Zotepin; Tipični antipsihotici: Hlorpromazin • Loksapin; Drugi: Butaklamol • EGIS-12,233 • Ketanserin • LY-215,840 • Metitepin/Metiotepin • Pimozid • Ritanserin • SB-258,719 • SB-258,741 • SB-269,970 • SB-656,104 • SB-656,104-A • SB-691,673 • SLV-313 • SLV-314 • Spiperon • SSR-181,507 |
|---|
|
|
|
|
|
|
